215 related articles for article (PubMed ID: 1725631)
41. [The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study].
Suárez A; Rodríguez M; Riestra S; Navascués CA; San Román FS; Otero L; Martínez A; Rodrigo L
Med Clin (Barc); 1994 Nov; 103(16):606-10. PubMed ID: 7996916
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of antibody to hepatitis C virus in a blood donor population.
Richards C; Holland P; Kuramoto K; Douville C; Randell R
Transfusion; 1991 Feb; 31(2):109-13. PubMed ID: 1847559
[TBL] [Abstract][Full Text] [Related]
43. [Reduction of the proportion of anti-HCV-positive donations].
Quiles FJ; Sanz A; Cabanillas A; Sáenz P; Sánchez GM; Díaz F
Sangre (Barc); 1992 Apr; 37(2):153-4. PubMed ID: 1320294
[No Abstract] [Full Text] [Related]
44. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
[TBL] [Abstract][Full Text] [Related]
45. Post-transfusion hepatitis C virus infection.
Kleinman S; Busch M; Holland P
N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
[No Abstract] [Full Text] [Related]
46. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
[No Abstract] [Full Text] [Related]
47. [Viral hepatitis and blood transfusion].
Larsen J; Hetland G; Skaug K; Maeland A
Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
[TBL] [Abstract][Full Text] [Related]
48. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
Takano S; Omata M; Ohto M; Nakamura K
Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
[TBL] [Abstract][Full Text] [Related]
49. [Serological study on hepatitis C (HCV) in 4371 blood donors].
Arnone M; Pinducciu G; Usai M; Pitzus F; Pintus L
Ann Ig; 1990; 2(5):353-8. PubMed ID: 1715726
[No Abstract] [Full Text] [Related]
50. [Results of detection of hepatitis C virus antibodies (anti-HCV) in blood donors and selected patients].
Nováková J; Pokorná G; Hrubisko M
Vnitr Lek; 1992 Jan; 38(1):45-8. PubMed ID: 1314004
[TBL] [Abstract][Full Text] [Related]
51. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.
MMWR Recomm Rep; 1991 Apr; 40(RR-4):1-17. PubMed ID: 1850496
[TBL] [Abstract][Full Text] [Related]
52. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
[TBL] [Abstract][Full Text] [Related]
53. Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia.
Abdelaal M; Rowbottom D; Zawawi T; Scott T; Gilpin C
Transfusion; 1994 Feb; 34(2):135-7. PubMed ID: 8310483
[TBL] [Abstract][Full Text] [Related]
54. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
Ebeling F
Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus prevalence and incidence estimates among Chinese blood donors.
Fu P; Lv Y; Zhang H; Liu C; Wen X; Ma H; He T; Ke L; Wu B; Liu J; He M; Liao D; Wang J; Ness P; Liu Y; Shan H;
Transfusion; 2019 Sep; 59(9):2913-2921. PubMed ID: 31271469
[TBL] [Abstract][Full Text] [Related]
56. [Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].
Slama H; Mojaat N; Dahri R; Boukef K
Rev Fr Transfus Hemobiol; 1991 Dec; 34(6):459-64. PubMed ID: 1663358
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of hepatitis C virus antibodies in Sydney blood donors.
Archer GT; Buring ML; Clark B; Ismay SL; Kenrick KG; Purusothaman K; Kaldor JM; Bolton WV; Wylie BR
Med J Aust; 1992 Aug; 157(4):225-7. PubMed ID: 1279363
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of anti-HCV in subjects of various age groups.
Albano A; Pianetti A; Biffi MR; Bruscolini F; Baffone W; Albano V; Salvaggio A
Eur J Epidemiol; 1992 Mar; 8(2):309-11. PubMed ID: 1379536
[TBL] [Abstract][Full Text] [Related]
59. [Anti-hepatitis C virus screening to prevent hepatitis C virus infection in blood donors].
Sun Y; Zhao Y; Liu X
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):696-9. PubMed ID: 8731835
[TBL] [Abstract][Full Text] [Related]
60. [The incidence of detecting antibodies to the hepatitis C virus in different population groups in the USSR].
Viazov SO; Kuzin SN; Orlova NG; Shakhgil'dian IV; Andriutsa KA; Paladi NE; Asfandiiarova NS; Buriev AIa; Savin EA; Bryzgalov SP
Vopr Virusol; 1991; 36(5):366-8. PubMed ID: 1725075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
